Roddie Gantt, MD
Pain Medicine · Huntsville, ALNPI 1912996059
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Abbott at 53.9% of the total. Reporting peaked in 2023 at $168 and has fallen 58.0% since, to $71 in 2025. That places this record below the midpoint for pain medicine clinicians in AL, where the typical reported total is $1,761.
Across 26 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$290
- AbbVie$74
- Medtronic$43
- Tersera Therapeutics LLC$34
- Almatica Pharma LLC$27
- Zyla Life Sciences, Inc.$24
- plus $47 from 3 others
What the payments were for
- Food & beverage$539100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $290 |
| AbbVie | 3 | $74 |
| Medtronic | 2 | $43 |
| Tersera Therapeutics LLC | 2 | $34 |
| Almatica Pharma LLC | 2 | $27 |
| Zyla Life Sciences, Inc. | 1 | $24 |
| Boston Scientific | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
How this compares
$539 in reported general payments places this provider in the 35th percentile of 77 pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 4,372 | $82,046 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,998 | $43,447 |
| Nucynta ErTapentadol Hcl | 26 | $22,829 |
| BelbucaBuprenorphine Hcl | 29 | $22,782 |
| Gabapentin | 1,634 | $19,371 |
| Oxycodone Hcl | 614 | $7,892 |
| Xtampza ErOxycodone Myristate | 14 | $7,203 |
| Naloxone Hcl | 84 | $5,878 |
| OxycontinOxycodone Hcl | 13 | $5,742 |
| Buprenorphine | 18 | $5,486 |
| Pregabalin | 427 | $5,254 |
| Morphine Sulfate ErMorphine Sulfate | 162 | $4,174 |
| Tramadol Hcl | 392 | $3,234 |
| Morphine Sulfate | 81 | $2,136 |
| Fentanyl | 24 | $1,410 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Huntsville
- Michael CosgroveHuntsville$25K
- James ThackerHuntsville$13K
- John RobertsHuntsville$7K
- Thomas KrausHuntsville$2K
- Ronald CollinsHuntsville$837
- Morris ScherlisHuntsville$527
- Christopher PaulBirmingham$64K
- Ron PitkanenMountain Brk$16K
- Elliott PenningtonDaphne$15K
- Grant StoneMobile$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.